# ITIH4 attenuates acute lung injury by Fe-containing particulate matter in mice via Hippo pathway in type II alveolar epithelial cells

**Authors:** Vincent Laiman, Syue-Wei Peng, Lina Choridah, Didik Setyo Heriyanto, Fara Silvia Yuliani, Kang-Yun Lee, Ching-Huang Lai, Jer-Hwa Chang, Yueh-Lun Lee, Shu-Chuan Ho, Sheng-Ming Wu, Chia-Li Han, Cheng-Wei Lin, Kian Fan Chung, Hsiao-Chi Chuang

PMC · DOI: 10.1186/s12931-025-03256-z · Respiratory Research · 2025-05-28

## TL;DR

ITIH4 reduces lung damage in mice exposed to iron-containing particles by regulating the Hippo pathway in lung cells.

## Contribution

This study reveals a novel role of ITIH4 in mitigating Fe-induced acute lung injury via Hippo pathway modulation in alveolar epithelial cells.

## Key findings

- rITIH4 treatment reversed Fe- and DEP-induced lung inflammation and Hippo pathway dysregulation.
- rITIH4 reduced neutrophil infiltration and monocyte depletion in bronchoalveolar lavage fluid.
- ITIH4 modulated Hippo pathway markers like p-YAP and pTAZ in type II alveolar epithelial cells.

## Abstract

Metals in particulate matter (PM), like iron (Fe), were associated with lung injury. Inter-alpha-trypsin inhibitor heavy chain H4 (ITIH4) was suggested to inhibit lung inflammation. However, the effect of metals in PM, particularly Fe, on lung inflammation involving ITIH4 remained unclear.

We investigated the effects of recombinant ITIH4 (rITIH4) against acute lung injury in C57BL/6JNarl and B6.Sftpc-CreERT2;Ai14(RCL-tdT)-D mice exposed to Fe-containing PM. Mice were exposed to diesel exhaust particles (DEP) or soluble iron (FeCl₃) via intratracheal instillation, while rITIH4 treatment was administered intranasally after exposure. Lung function, Fe levels (both bulk and single-cell by inductively-coupled plasma mass spectrometry (ICP-MS) and single-cell ICP-MS, respectively), inflammatory cell infiltration, and Hippo pathway regulation in type II alveolar epithelial cells (AECII) were assessed.

We observed correlation between lung function changes and Fe levels, both in bulk and single-cell Fe in peripheral blood mononuclear cells. Single-cell RNA sequencing of the control group identified AECII-related cells characterized by high Sftpc, Sftpa1, Mzb1, B3 gnt5, Cacna1e, and Agbl1 expression. rITIH4 treatment in DEP-exposed mice restored Hippo pathway Cdh1, Itih4, Pdpn, Wwtr1, and Yap1 in AECII. rITIH4 reversed DEP- and Fe-induced increases in neutrophil infiltration, neutrophil-to-lymphocyte ratio, and monocyte depletion in bronchoalveolar lavage fluid (BALF). rITIH4 reduced BALF CXCL1/KC levels by DEP and serum 8-isoprostane levels by Fe. rITIH4 also reduced DEP-induced lung damage, increased ⍺-catenin and p-YAP in Fe-exposed mice, and pTAZ/TAZ ratio in both DEP- and Fe-exposed mice. rITIH4 increased pYAP/YAP ratio in DEP-exposed mice while decreasing LC3BII/I ratio in Fe-exposed mice.

ITIH4 attenuated acute lung injury in mice exposed to PM, specifically Fe, by modulating the Hippo pathway in AECII.

The online version contains supplementary material available at 10.1186/s12931-025-03256-z.

## Linked entities

- **Genes:** SFTPC (surfactant protein C) [NCBI Gene 6440], SFTPA1 (surfactant protein A1) [NCBI Gene 653509], MZB1 (marginal zone B and B1 cell specific protein) [NCBI Gene 51237], B3GNT5 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5) [NCBI Gene 84002], CACNA1E (calcium voltage-gated channel subunit alpha1 E) [NCBI Gene 777], AGBL1 (AGBL carboxypeptidase 1) [NCBI Gene 123624], CDH1 (cadherin 1) [NCBI Gene 999], ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4) [NCBI Gene 3700], PDPN (podoplanin) [NCBI Gene 10630], WWTR1 (WW domain containing transcription regulator 1) [NCBI Gene 25937], YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413], CTNNA1 (catenin alpha 1) [NCBI Gene 1495], YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413], TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901], MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631]
- **Proteins:** ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4)
- **Chemicals:** Fe (PubChem CID 23925), 8-isoprostane (PubChem CID 5282263)
- **Diseases:** acute lung injury (MONDO:0006502)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Cacna1e (calcium channel, voltage-dependent, R type, alpha 1E subunit) [NCBI Gene 12290] {aka A430040I15, BII, Cach6, Cacnl1a6, Cav2.3, Cchra1}, Sftpc (surfactant associated protein C) [NCBI Gene 20389] {aka Bricd6, SP-C, SP5, SPC, Sftp-2, Sftp2}, Sftpa1 (surfactant associated protein A1) [NCBI Gene 20387] {aka SP-A, Sftp-1, Sftp1}, Itih4 (inter alpha-trypsin inhibitor, heavy chain 4) [NCBI Gene 16427] {aka ITI-HC4, Itih-4, PK-120}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Wwtr1 (WW domain containing transcription regulator 1) [NCBI Gene 97064] {aka 2310058J06Rik, 2610021I22Rik, Taz}, Pdpn (podoplanin) [NCBI Gene 14726] {aka E11, Gp38, OTS-8, RANDAM-2, T1-alpha, T1a}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, Tafazzin (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 66826] {aka 5031411C02Rik, 9130012G04Rik, G4.5, Taz}, Agbl1 (ATP/GTP binding protein-like 1) [NCBI Gene 244071] {aka Ccp4, D430020F16, EG244071, Nna1-l1}, Cdh1 (cadherin 1) [NCBI Gene 12550] {aka ARC-1, E-cad, Ecad, L-CAM, UVO, Um}, Mzb1 (marginal zone B and B1 cell-specific protein 1) [NCBI Gene 69816] {aka 2010001M09Rik, PACAP, pERp1}
- **Diseases:** inflammatory (MESH:D007249), lung injury (MESH:D055370), lung damage (MESH:D008171), lung inflammation (MESH:D011014), acute lung injury (MESH:D055371)
- **Chemicals:** FeCl₃ (MESH:C024555), 8-isoprostane (MESH:C075750), Fe (MESH:D007501), DEP (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** type — Homo sapiens (Human), Transformed cell line (CVCL_G005)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12121068/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12121068/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12121068/full.md

---
Source: https://tomesphere.com/paper/PMC12121068